Upgrade to SI Premium - Free Trial

Zymeworks (ZYME) PT Raised to $51 at H.C. Wainwright

August 6, 2026 6:55 AM
H.C. Wainwright analyst Andrew Berens raised the price target on Zymeworks (NASDAQ: ZYME) to $51.00 (from $46.00) while maintaining a Buy rating.

Categories

Analyst PT Change